COMPLETED

Improving Patient Memory for Treatment for Mild Cognitive Impairment

Conditions

Memory Impairment Sleep Disorder mild cognitive impairment sleep and circadian functioning improving treatment outcome

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The main empirical question to be addressed is: What types of memory support are most potent for patients who are experiencing a mild cognitive impairment (MCI) relative to non-MCI patients?

Official Title

Improving Memory for Treatment for Patients Experiencing Mild Cognitive Impairment: Are Constructive or Non-constructive Memory Supports More Helpful?

Quick Facts

Study Start:2023-05-19

Study Completion:2025-06-26

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT05668481

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Participants 60 years and older will be recruited. 2. Fluent in English. 3. Experiencing some difficulties relating to sleep and circadian functioning and (d) a score of 19-25 on the Montreal Cognitive Assessment (for the MCI group) and score 26-30 on the Montreal Cognitive Assessment (for the non-MCI group) (e) Have a computer to use and an internet connection and (f) be able to attend sessions weekly and on the same day each week.	1. Presence of an active and progressive mental or physical illness or neurological degenerative disease; 2. Night shift work \>2 nights per week in the past 3 months; 3. Not able and willing to participate in and/or complete the assessments and participate in the treatment.

Inclusion Criteria

Exclusion Criteria

1. Participants 60 years and older will be recruited.
2. Fluent in English.
3. Experiencing some difficulties relating to sleep and circadian functioning and (d) a score of 19-25 on the Montreal Cognitive Assessment (for the MCI group) and score 26-30 on the Montreal Cognitive Assessment (for the non-MCI group) (e) Have a computer to use and an internet connection and (f) be able to attend sessions weekly and on the same day each week.

1. Presence of an active and progressive mental or physical illness or neurological degenerative disease;
2. Night shift work \>2 nights per week in the past 3 months;
3. Not able and willing to participate in and/or complete the assessments and participate in the treatment.

Contacts and Locations

Study Locations (Sites)

University of California, Berkeley

Berkeley, California, 94720-1650

United States

Collaborators and Investigators

Sponsor: University of California, Berkeley

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-19

Study Completion Date2025-06-26

Study Record Updates

Study Start Date2023-05-19

Study Completion Date2025-06-26

Terms related to this study

Keywords Provided by Researchers

mild cognitive impairment
sleep and circadian functioning
improving treatment outcome

Additional Relevant MeSH Terms

Memory Impairment
Sleep Disorder